Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H8N2 |
Molecular Weight | 144.1732 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=C2C=CC=CC2=NC=C1
InChI
InChIKey=FQYRLEXKXQRZDH-UHFFFAOYSA-N
InChI=1S/C9H8N2/c10-8-5-6-11-9-4-2-1-3-7(8)9/h1-6H,(H2,10,11)
Molecular Formula | C9H8N2 |
Molecular Weight | 144.1732 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes and Vero cells: inhibition of channel function by chloroquine and related compounds in vitro and intoxification in vivo. | 2001 Jul |
|
Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? | 2001 Jun |
|
3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates. | 2002 Mar 5 |
|
Double-drug development against antioxidant enzymes from Plasmodium falciparum. | 2003 |
|
Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. | 2003 Aug |
|
Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties. | 2003 Aug |
|
Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials. | 2003 Nov 6 |
|
Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine. | 2003 Sep 19 |
|
Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites. | 2004 Apr 1 |
|
Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts. | 2004 Aug 2 |
|
A correlation study of quinoline derivatives and their pharmaceutical behavior by ab initio calculated NQR parameters. | 2004 Mar |
|
Molecular analysis of Plasmodium falciparum from drug treatment failure patients in Papua New Guinea. | 2004 Mar |
|
Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. | 2004 Mar 5 |
|
A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile. | 2004 May 6 |
|
Parallel synthesis and antimalarial screening of a 4-aminoquinoline library. | 2004 May-Jun |
|
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. | 2004 Oct 8 |
|
1,4-bis(3-aminopropyl)piperazine libraries: from the discovery of classical chloroquine-like antimalarials to the identification of new targets. | 2005 Feb |
|
Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities. | 2005 Feb 15 |
|
Design and synthesis of new antimalarial agents from 4-aminoquinoline. | 2005 Mar 15 |
|
A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs. | 2006 |
|
Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a 'catch and release' protocol. | 2006 Aug 15 |
|
Probing the role of the covalent linkage of ferrocene into a chloroquine template. | 2006 Jul 27 |
|
Susceptibility of Colombian Plasmodium falciparum isolates to 4-aminoquinolines and the definition of amodiaquine resistance in vitro. | 2006 May |
|
Genotoxicity of chloroquine in rat liver cells: protective role of free radical scavengers. | 2006 May |
|
The use of antirheumatic disease drugs during pregnancy. | 2006 Nov |
|
Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea. | 2006 Nov |
|
4-Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1R) antagonists. | 2006 Oct 15 |
|
Fujita-Ban QSAR analysis and CoMFA study of quinoline antagonists of immunostimulatory CpG-oligodeoxynucleotides. | 2007 Jan 1 |
|
Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives. | 2007 Jan 25 |
|
In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border. | 2007 Jun 27 |
|
Exploration of rate-limiting conformational state for 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl][1,1'-biphenyl]-2-ols and N(omega)-oxides (tebuquine analogues) for antimalarial activity using molecular shape analysis and molecular field analysis studies. | 2007 May-Jun |
|
Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase. | 2008 Aug 15 |
|
Antiplasmodial, beta-haematin inhibition, antitrypanosomal and cytotoxic activity in vitro of novel 4-aminoquinoline 2-imidazolines. | 2008 Dec 7 |
|
[Urotensin II promotes atherosclerosis]. | 2008 Jan |
|
Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice. | 2008 Oct |
|
Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline. | 2008 Sep |
|
Synthesis and antimalarial activity of new amino analogues of amodiaquine. | 2008 Sep |
|
Antimalarial activities of ferroquine conjugates with either glutathione reductase inhibitors or glutathione depletors via a hydrolyzable amide linker. | 2009 Dec 1 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:10:37 GMT 2023
by
admin
on
Fri Dec 15 17:10:37 GMT 2023
|
Record UNII |
GTE5P5L97N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
GTE5P5L97N
Created by
admin on Fri Dec 15 17:10:37 GMT 2023 , Edited by admin on Fri Dec 15 17:10:37 GMT 2023
|
PRIMARY | |||
|
C001920
Created by
admin on Fri Dec 15 17:10:37 GMT 2023 , Edited by admin on Fri Dec 15 17:10:37 GMT 2023
|
PRIMARY | |||
|
578-68-7
Created by
admin on Fri Dec 15 17:10:37 GMT 2023 , Edited by admin on Fri Dec 15 17:10:37 GMT 2023
|
PRIMARY | |||
|
68476
Created by
admin on Fri Dec 15 17:10:37 GMT 2023 , Edited by admin on Fri Dec 15 17:10:37 GMT 2023
|
PRIMARY | |||
|
DTXSID70206491
Created by
admin on Fri Dec 15 17:10:37 GMT 2023 , Edited by admin on Fri Dec 15 17:10:37 GMT 2023
|
PRIMARY | |||
|
4-AMINOQUINOLINE
Created by
admin on Fri Dec 15 17:10:37 GMT 2023 , Edited by admin on Fri Dec 15 17:10:37 GMT 2023
|
PRIMARY |